UPMC-developed test increases odds of correct surgery for thyroid cancer patients
7/25/2014
The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer, report...
Is Europe putting cancer research at risk?
7/25/2014
The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General Data...
Biosimilar Retacrit™ effective in chemotherapy-induced anemia
7/25/2014
Hospira, the world's leading provider of injectable drugs and infusion technologies, announced today that the results from the ORHEO study (place of biOsimilaRs in the therapeutic management of...
FDA approves Zydelig for three types of blood cancers
7/25/2014
The U.S. Food and Drug Administration has approved Zydelig (idelalisib) to treat patients with three types of blood cancers.
Shrinking oral cancers with anti-pain agent spares healthy tissues
7/25/2014
Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School...
Four biological subtypes of stomach cancer defined
7/25/2014
In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared...
Innovative methodology enables non-coding DNA to be decoded in colorectal cancer
7/25/2014
Cancer is a disease of the genome resulting from a combination of genetic modifications (or mutations).
How neuro cells turn cancerous
7/25/2014
Scientists from the Sloan-Kettering Institute for Cancer Research in New York with the help of Plymouth University Peninsula Schools of Medicine and Dentistry have completed research which for the...
Pathogenic connection found between autoimmune disorders and cancer
7/25/2014
Autoimmune disorders may share certain pathogenic mechanisms with cancer, according to a new report by George Washington University (GW) researcher Linda Kusner, Ph.D., published in PLOS ONE.
Increased risk for head, neck cancers in patients with diabetes
7/24/2014
Diabetes mellitus (DM) appears to increase the risk for head and neck cancer (HNC).